Abstract:Abstract Acute myeloid leukemia (AML) is often accompanied with the aberrant expression of transcription factors. In t(8;21) AML, the AML1-ETO fusion protein executes its critical role in leukemogenesis through the interference with hematopoietic transcription factors (TFs) including AML1, C/EBPα, PU.1 and c-Myb. These transcription factors cooperate to modulate hematopoiesis by regulating their differentiation-related target genes. In our previous work, we have identified that AML1-ETO suppresses the AML1-dependent transactivation of the gene encoding the neutrophil granule protease, cathepsin G (CTSG). However, the detailed mechanisms of AML1-ETO mediated transrepression, especially coordinated regulation of hematopoietic transcription factors, have not been characterized yet. To investigate the regulatory pattern of CTSG by hematopoietic specific transcription factors, we constructed a luciferase reporter containing the CTSG promoter and co-transfect it with AML1, c-Myb, C/EBPα or PU.1 to 293T cells. The results of luciferase assays showed that these TFs individually activated the CTSG promoter, and synergistic transactivation occurred between AML1 and c-Myb, C/EBPα and PU.1, and PU.1 and c-Myb on the CTSG promoter. Furthermore, AML1/ETO effectively suppressed the transcription factor-dependent transactivation and synergistic transactivation of the CTSG promoter. Chromatin immunoprecipitation assays further demonstrated that AML1-ETO coexisted with these TFs on the CTSG promoter in AML1/ETO-positive Kasumi-1 cell line, indicating AML1-ETO was tethered to the chromatin bound by these TFs. The data suggested that AML1-ETO might act as a negative regulator by interfering the normal function of hematopoietic TFs instead of competing for their binding. In addition, to reveal the underlying mechanism of AML1/ETO-mediated transcription repression at the epigenetic level, we examined the epigenetic status of the CTSG promoter in AML1-ETO negative and positive cells, and found the level of histone H3 Lys9 acetylation on the CTSG promoter was obviously lower in AML1-ETO positive cells than that in AML1-ETO negative cells. The data suggested that AML1-ETO might repress the gene transcription by changing the H3 acetylation status of its target gene. Collectively, our findings demonstrate that AML1-ETO represses the transactivation of the CTSG promoter mediated by multiple hematopoietic transcription factors through a decrease of H3 acetylation. Disclosures: No relevant conflicts of interest to declare.

A Novel Transcript Encoding an N-terminally Truncated AML1/PEBP2 Alphab Protein Interferes with Transactivation and Blocks Granulocytic Differentiation of 32dcl3 Myeloid Cells

A Distinct Epigenetic Signature at Targets of a Leukemia Protein

[The Effects of Different Transcripts of AML1 on the Transactivation of M-CSF-R Gene].

JMJD3 Facilitates C/EBPβ-centered Transcriptional Program to Exert Oncorepressor Activity in AML

Rar Alpha-Plzf Oncogene Inhibits C/Ebp Alpha Function In Myeloid Cells

Negative Regulation of Granulocytic Differentiation in the Myeloid Precursor Cell Line 32dcl3 Byear-2, a Mammalian Homolog Ofdrosophila Seven-Up, and a Chimeric Leukemogenic Gene,aml1/eto(mtg8)

[Influence of AML1 and AML1-ETO on Transcriptional Regulation of Nucb2 Gene].

Overexpression of an Isoform of AML1 in Acute Leukemia and Its Potential Role in Leukemogenesis

Nls-Rar Alpha Promotes Proliferation And Inhibits Differentiation In Hl-60 Cells

Role of AML1a in Abnormal Proliferation and Differentiation of Murine Hematopoietic Cells

ZFP36L2, a Novel AML1 Target Gene, Induces AML Cells Apoptosis and Inhibits Cell Proliferation

RARα-PLZF Oncogene Inhibits C/EBPα Function in Myeloid Cells

Inhibition of Long Non-Coding RNA NEAT1 Impairs Myeloid Differentiation in Acute Promyelocytic Leukemia Cells.

Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid Leukemia

Lentivirus-mediated RNA Interference Targeting FAMLF-1 Inhibits Cell Growth and Enhances Cell Differentiation of Acute Myeloid Leukemia Partially Differentiated Cells Via Inhibition of AKT and C-Myc

Trdmt1 3'-Untranslated Region Functions As a Competing Endogenous RNA in Leukemia HL-60 Cell Differentiation

A Novel Transcript of the LMO2 Gene, LMO2-c, is Regulated by GATA-1 and PU.1 and Encodes an Antagonist of LMO2

Mutant NPM1 hijacks transcriptional hub to maintain pathogenic gene programs in acute myeloid leukemia

Declined Presentation Heterogeneous Nuclear Ribonucleoprotein D-like Promotes the Growth of Chronic Myeloid Leukemia Cells Via Pre-B-cell Leukemia Homeobox 1

ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6

AML1-ETO Represses Multiple Transcription Factor Induced CTSG Activation by Reducing H3 Acetylation